Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors.
Saved in:
| Title: | Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors. |
|---|---|
| Authors: | Tan YN; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China., Huang JD; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; School of Biomedical Sciences, The University of Hong Kong, Hong Kong, 00852, China., Li YP; Department of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen, 518000, China., Li SS; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China., Luo M; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China., Luo J; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 00852, China., Lee AW; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 00852, China., Fu L; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and International Cancer Center, Shenzhen University Health Science Center, Shenzhen, 518060, China., Hu FQ; College of Pharmaceutical Science, Zhejiang University, Hangzhou, 310058, China., Guan XY; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 00852, China. |
| Source: | Advanced healthcare materials [Adv Healthc Mater] 2022 Mar; Vol. 11 (6), pp. e2101496. Date of Electronic Publication: 2021 Dec 17. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101581613 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2192-2659 (Electronic) Linking ISSN: 21922640 NLM ISO Abbreviation: Adv Healthc Mater Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34878725 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tan+YN%22">Tan YN</searchLink>; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.<br /><searchLink fieldCode="AU" term="%22Huang+JD%22">Huang JD</searchLink>; Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, China.; School of Biomedical Sciences, The University of Hong Kong, Hong Kong, 00852, China.<br /><searchLink fieldCode="AU" term="%22Li+YP%22">Li YP</searchLink>; Department of Urology, The Third Affiliated Hospital of Shenzhen University (Luohu Hospital Group), Shenzhen, 518000, China.<br /><searchLink fieldCode="AU" term="%22Li+SS%22">Li SS</searchLink>; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.<br /><searchLink fieldCode="AU" term="%22Luo+M%22">Luo M</searchLink>; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.<br /><searchLink fieldCode="AU" term="%22Luo+J%22">Luo J</searchLink>; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 00852, China.<br /><searchLink fieldCode="AU" term="%22Lee+AW%22">Lee AW</searchLink>; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 00852, China.<br /><searchLink fieldCode="AU" term="%22Fu+L%22">Fu L</searchLink>; Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and International Cancer Center, Shenzhen University Health Science Center, Shenzhen, 518060, China.<br /><searchLink fieldCode="AU" term="%22Hu+FQ%22">Hu FQ</searchLink>; College of Pharmaceutical Science, Zhejiang University, Hangzhou, 310058, China.<br /><searchLink fieldCode="AU" term="%22Guan+XY%22">Guan XY</searchLink>; Department of Clinical Oncology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, 518053, China.; Department of Clinical Oncology, The University of Hong Kong, Hong Kong, 00852, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581613%22">Advanced healthcare materials</searchLink> [Adv Healthc Mater] 2022 Mar; Vol. 11 (6), pp. e2101496. <i>Date of Electronic Publication: </i>2021 Dec 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-VCH%22">Wiley-VCH </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101581613 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2192-2659 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221922640%22">21922640 </searchLink><i>NLM ISO Abbreviation: </i>Adv Healthc Mater <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34878725 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/adhm.202101496 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e2101496 Titles: – TitleFull: Near-Infrared Responsive Membrane Nanovesicles Amplify Homologous Targeting Delivery of Anti-PD Immunotherapy against Metastatic Tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tan YN – PersonEntity: Name: NameFull: Huang JD – PersonEntity: Name: NameFull: Li YP – PersonEntity: Name: NameFull: Li SS – PersonEntity: Name: NameFull: Luo M – PersonEntity: Name: NameFull: Luo J – PersonEntity: Name: NameFull: Lee AW – PersonEntity: Name: NameFull: Fu L – PersonEntity: Name: NameFull: Hu FQ – PersonEntity: Name: NameFull: Guan XY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2022 Mar Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2192-2659 Numbering: – Type: volume Value: 11 – Type: issue Value: 6 Titles: – TitleFull: Advanced healthcare materials Type: main |
| ResultId | 1 |